Submitted by filosoful t3_yohk56 in Futurology
Comments
FuturologyBot t1_iveaeb3 wrote
The following submission statement was provided by /u/filosoful:
Blood that has been grown in a laboratory has been put into people in a world-first clinical trial, UK researchers say
Tiny amounts - equivalent to a couple of spoonfuls - are being tested to see how it performs inside the body.
The bulk of blood transfusions will always rely on people regularly rolling up their sleeve to donate.
But the ultimate goal is to manufacture vital, but ultra-rare, blood groups that are hard to get hold of.
These are necessary for people who depend on regular blood transfusions for conditions such as sickle cell anaemia.
Please reply to OP's comment here: https://old.reddit.com/r/Futurology/comments/yohk56/labgrown_blood_given_to_people_in_worldfirst/ive88th/
sonoma95436 t1_ivebubx wrote
Fluosol-DA-20 was tested in 1979 in Japan and approved in 1989 by the FDA and withdrawn five years later. I could not find a explination.
OhYouRye t1_iveof51 wrote
> In early 1994, however, Green Cross ceased manufacturing Fluosol due to lack of interest from physicians and poor sales in their angioplasty indication (Table 25.1). Improvements in PTCA technology, notably the introduction of specialized autoperfusion catheters, made the need for Fluosol redundant.
Rudy_Gin_Fizz t1_ivf9srk wrote
Zombies...I was thinking Vampire apocalypse as they will no longer need to rely on humans for food and can eliminate us.
Malbraho t1_ivfb894 wrote
I was thinking like the "I am legend" or Omega man story, or countless others where they create a cure that affects us in some drastic way
Rudy_Gin_Fizz t1_ivfep15 wrote
Either way it is a far more interesting apocalypse than a Covid Variant that kills everyone or Putin nuking the planet.
Malbraho t1_ivfqspj wrote
No argument here haha
Soopermoose t1_ivfz59n wrote
Good to see Michael Morbius finally got his Dream project off the ground, and is ready for human trials.
filosoful OP t1_ive88th wrote
Blood that has been grown in a laboratory has been put into people in a world-first clinical trial, UK researchers say
Tiny amounts - equivalent to a couple of spoonfuls - are being tested to see how it performs inside the body.
The bulk of blood transfusions will always rely on people regularly rolling up their sleeve to donate.
But the ultimate goal is to manufacture vital, but ultra-rare, blood groups that are hard to get hold of.
These are necessary for people who depend on regular blood transfusions for conditions such as sickle cell anaemia.